GoodRx/GDRX

$6.83

-3.17%
-
1D1W1MYTD1YMAX

About GoodRx

GoodRx Holdings, Inc. provides a consumer-focused digital healthcare platform in the United States. It offer consumers free access to transparent and lower prices for generic and brand medications, as well as comprehensive healthcare research and information. It also equips healthcare professionals to find and prescribe affordable medications. It offers information and tools to help consumers compare prices and save on their prescription drug purchases. It operates a price comparison platform that provides consumers with geographically relevant prescription pricing and provides access to negotiated prices through its codes that can be used to save money on prescriptions across the United States (the prescription transactions offering). It also offers other healthcare products and services, including pharmaceutical manufacturer solutions, subscriptions, and telehealth services. Its subscription offerings provide additional benefits to consumers of its prescription transactions offering.

Ticker

GDRX

Sector

Technology

Trading on

NASDAQ

Industry

Business Services

CEO

Scott Wagner

Employees

694

Headquarters

Santa monica, United States

GoodRx Metrics

BasicAdvanced
$2.73B
Market cap
-
P/E ratio
-$0.02
EPS
1.42
Beta
-
Dividend rate
$2.73B
1.42014
$9.37
$4.14
1.42M
7.121
85.005
86.158
63.15
0.54%
-0.56%
-1.12%
-0.59%
3.643
3.579
14.028
33.121
-2.12%
70.98%
10.86%

What the Analysts think about GoodRx

Analyst Ratings

Majority rating from 20 analysts.
Buy

Price Targets

Average projection from 17 analysts.
28.26% upside
High $14.00
Low $5.00
$6.83
Current price
$8.76
Average price target

GoodRx Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-13.12% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$196.6M
9.28%
Net income
$-25.8M
-32.81%
Profit margin
-13.12%
-38.52%

GoodRx Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 18.52%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$0.07
$0.07
$0.06
$0.08
-
Expected
$0.06
$0.06
$0.06
$0.07
$0.08
Surprise
25.28%
15.77%
3.81%
18.52%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for GoodRx stock?

GoodRx (GDRX) has a market cap of $2.73B as of April 13, 2024.

What is the P/E ratio for GoodRx stock?

The price to earnings (P/E) ratio for GoodRx (GDRX) stock is 0 as of April 13, 2024.

Does GoodRx stock pay dividends?

No, GoodRx (GDRX) stock does not pay dividends to its shareholders as of April 13, 2024.

When is the next GoodRx dividend payment date?

GoodRx (GDRX) stock does not pay dividends to its shareholders.

What is the beta indicator for GoodRx?

GoodRx (GDRX) has a beta rating of 1.42. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the GoodRx stock price target?

The target price for GoodRx (GDRX) stock is $8.76, which is 28.26% above the current price of $6.83. This is an average based on projections from 17 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell GoodRx stock

Buy or sell GoodRx stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing